121 related articles for article (PubMed ID: 35759117)
21. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment.
Yu L; Cao S; Li J; Han B; Zhong H; Zhong R
Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738
[TBL] [Abstract][Full Text] [Related]
22. NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.
Liu XS; Zhou LM; Yuan LL; Gao Y; Kui XY; Liu XY; Pei ZJ
Front Immunol; 2021; 12():724741. PubMed ID: 34335635
[TBL] [Abstract][Full Text] [Related]
23. Immune landscape and a promising immune prognostic model associated with TP53 in early-stage lung adenocarcinoma.
Wu C; Rao X; Lin W
Cancer Med; 2021 Feb; 10(3):806-823. PubMed ID: 33314730
[TBL] [Abstract][Full Text] [Related]
24. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.
Wang W; Ren S; Wang Z; Zhang C; Huang J
Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive Analysis of YTH Domain Family in Lung Adenocarcinoma: Expression Profile, Association with Prognostic Value, and Immune Infiltration.
Hu K; Yao L; Yan Y; Zhou L; Li J
Dis Markers; 2021; 2021():2789481. PubMed ID: 34497675
[TBL] [Abstract][Full Text] [Related]
26. MRPL12 Acts as A Novel Prognostic Biomarker Involved in Immune Cell Infiltration and Tumor Progression of Lung Adenocarcinoma.
Hu Y; Liu Y; Ma C; Ai K
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769082
[TBL] [Abstract][Full Text] [Related]
27. High Expression of
Deng H; Huang Y; Wang L; Chen M
Biomed Res Int; 2020; 2020():2071593. PubMed ID: 33134373
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma.
Li MX; Zhang MY; Dong HH; Li AJ; Teng HF; Liu AL; Xu N; Qu YQ
Int J Med Sci; 2021; 18(2):494-504. PubMed ID: 33390818
[No Abstract] [Full Text] [Related]
29. Expression and Prognostic Significance of m6A-Related Genes in Lung Adenocarcinoma.
Zhang Y; Liu X; Liu L; Li J; Hu Q; Sun R
Med Sci Monit; 2020 Feb; 26():e919644. PubMed ID: 32086933
[TBL] [Abstract][Full Text] [Related]
30. The role of ATP-binding cassette subfamily A in the etiology of Alzheimer's disease.
Bossaerts L; Cacace R; Van Broeckhoven C
Mol Neurodegener; 2022 Apr; 17(1):31. PubMed ID: 35477481
[TBL] [Abstract][Full Text] [Related]
31. AHNAK2 Is Associated with Poor Prognosis and Cell Migration in Lung Adenocarcinoma.
Zhang S; Lu Y; Qi L; Wang H; Wang Z; Cai Z
Biomed Res Int; 2020; 2020():8571932. PubMed ID: 32904605
[TBL] [Abstract][Full Text] [Related]
32. Varied clinical significance of ATP-binding cassette C sub-family members for lung adenocarcinoma.
Zhang L; Huang P; Huang C; Jiang L; Lu Z; Wang P
Medicine (Baltimore); 2021 Apr; 100(16):e25246. PubMed ID: 33879658
[TBL] [Abstract][Full Text] [Related]
33. Function of low ADARB1 expression in lung adenocarcinoma.
Wang X; Xu Z; Ren X; Chen X; Wei J; Lin W; Li Z; Ou C; Gong Z; Yan Y
PLoS One; 2019; 14(9):e0222298. PubMed ID: 31491024
[TBL] [Abstract][Full Text] [Related]
34. High Expression of
Chen Y; Zhou M; Gu X; Wang L; Wang C
Dis Markers; 2022; 2022():8789515. PubMed ID: 35855850
[TBL] [Abstract][Full Text] [Related]
35. Cancer-testis antigen KK-LC-1 is a potential biomarker associated with immune cell infiltration in lung adenocarcinoma.
Kang Y; Gan Y; Jiang Y; You J; Huang C; Chen Q; Xu X; Chen F; Chen L
BMC Cancer; 2022 Jul; 22(1):834. PubMed ID: 35907786
[TBL] [Abstract][Full Text] [Related]
36. SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma.
Zhang X; Wu Z; Ma K
BMC Cancer; 2022 Apr; 22(1):406. PubMed ID: 35421944
[TBL] [Abstract][Full Text] [Related]
37. Prospective role and immunotherapeutic targets of sideroflexin protein family in lung adenocarcinoma: evidence from bioinformatics validation.
Dang HH; Ta HDK; Nguyen TTT; Anuraga G; Wang CY; Lee KH; Le NQK
Funct Integr Genomics; 2022 Oct; 22(5):1057-1072. PubMed ID: 35851932
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the prognostic values of solute carrier (SLC) family 39 genes for patients with lung adenocarcinoma.
Zhou H; Zhu Y; Qi H; Liang L; Wu H; Yuan J; Hu Q
Aging (Albany NY); 2021 Feb; 13(4):5312-5331. PubMed ID: 33535184
[TBL] [Abstract][Full Text] [Related]
39. DPYSL2 as potential diagnostic and prognostic biomarker linked to immune infiltration in lung adenocarcinoma.
Wu YJ; Nai AT; He GC; Xiao F; Li ZM; Tang SY; Liu YP; Ai XH
World J Surg Oncol; 2021 Sep; 19(1):274. PubMed ID: 34517904
[TBL] [Abstract][Full Text] [Related]
40. SLC2A5 Correlated with Immune Infiltration: A Candidate Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma.
Luo L; Su J; Zheng Y; Huang F; Huang R; Luo H
J Immunol Res; 2021; 2021():9938397. PubMed ID: 34604392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
